While the life sciences industry in Germany saw an overall decline in 2022, 2023 proved to be a source of improvement. Venture financing increased from USD 725m to USD 841m. However, biotech financing retracted, with both the number and value of rounds decreasing. In the Biotech – Therapeutics and Diagnostics sector, oncology remains by far … Continue reading Germany Life Science Trend Analysis 2024
Category: Life Sciences Reports
This area includes the yearly life sciences and Biotech reports with statistics retrieved from Biotechgate.
Switzerland Life Science Trend Analysis 2024
While the life sciences industry in Switzerland saw an overall decline in 2022, 2023 proved to be a source of improvement. Swiss biotechs raised USD 639 million, a 17% increase from the previous year. In Switzerland, 27% of all life science companies are biotechs, with a similar split between biotech therapeutics and diagnostics (45%) and … Continue reading Switzerland Life Science Trend Analysis 2024
France Life Science Trend Analysis 2024
The French life sciences industry continued to perform strongly in 2023, compared to other European countries like the Netherlands, Belgium, and Germany. Biotechnology companies make up 40% of the life sciences sector in France, with nearly half of these engaged in R&D services. Within the biotech – therapeutics and diagnostics sector, top key activities are … Continue reading France Life Science Trend Analysis 2024
UK Life Science Trend Analysis 2024
The UK government published the Science & Technology Framework in early 2023, signaling a robust strategy for the growth of the science and technology sector, with a focus on increasing private investment in R&D. Potentially a result of this strategic push, biotech private equity funding experienced a slight rise both in terms of the amount … Continue reading UK Life Science Trend Analysis 2024
Norway Life Science Trend Analysis 2024
In 2023, the Norwegian life science industry continues to show dynamism and innovation. With biotechnology companies comprising a substantial 48% of the life science sector, nearly half of these fall under the “Biotech – Other” category, which includes sectors such as AgBio, environmental, veterinary, and industrial biotechnology. Notably, digital health emerges as a key sector, … Continue reading Norway Life Science Trend Analysis 2024
Taiwan Life Science Trend Analysis 2024
While 2023 shows a declining trend in terms of private equity financing of Taiwanese life science companies since 2020, public financing surged year-on-year, raising more than twice as much as in 2022. The three largest private equity financing rounds in 2023 were completed by medical technology companies, led by Syncell, which raised USD 8 million. … Continue reading Taiwan Life Science Trend Analysis 2024
Canadian Life Science Trend Analysis 2024
In 2023, the Canadian biotech landscape showed stability, largely maintaining the financing levels of the previous year (USD 451 million in 2023 vs. USD 460 million in 2022), but falling short of the record year of 2021. Ontario once again proved to be Canada’s most active province, with the highest number of biotech companies and … Continue reading Canadian Life Science Trend Analysis 2024
Dutch Life Science Trend Analysis 2024: Market is slowly picking up
Biotechgate, the leading global biotech database, published their annual Trend Analysis Report 2024 of the Dutch life sciences sector in collaboration with hollandbio. In 2022, the Dutch biotech landscape saw a sharp 50% decline in venture financing, reflecting the challenging global economic climate. Fortunately, the tide seems to turn. In 2023, life sciences saw a … Continue reading Dutch Life Science Trend Analysis 2024: Market is slowly picking up
Maryland Life Science Trend Analysis 2024
Venture financing for Maryland’s life sciences industry in 2023 shows signs of recovery following the significant downturn in 2022, with the total value of private equity financing reaching USD 805m (up from USD 639m in 2022). For the biotech industry, the value of venture financing deals remained stable (USD 453m in 2022 vs. USD 451m … Continue reading Maryland Life Science Trend Analysis 2024
Norway Life Science Trend Analysis 2023
The Norwegian life sciences industry performed well in 2022 compared to the years before 2021 (2018 – 2020), raising USD 38 million in private equity investments according to Biotechgate data. However, it could not compete with the record level of venture financing in 2021 (USD 65 million). Cytovation ASA secured the largest round in 2022. … Continue reading Norway Life Science Trend Analysis 2023